SOD1 and amyotrophic lateral sclerosis: In line with this hypothesis, sodium phenylbutyrate, a drug used to treat increased ammonia levels in patients with urea cycle disorders [67], has recently been approved for use in ALS patients [68], after demonstrating its ability to promote motor neuronal survival in an SOD1-ALS-mouse model [69].